DOC — Healthpeak Properties, Inc.

Healthpeak Properties, Inc. (DOC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• FFO (Funds From Operations) as adjusted: $0.45 per share.
• Net debt-to-EBITDA ratio: 5.4x.
• Total occupancy in outpatient medical: 91%.
• Senior housing revenue growth: 35% with adjusted EBITDA growth of 42%.
• Dividend payout: Over $200 million in Q1, yielding an annualized 7.5%.
• Stock buyback: $100 million at an FFO yield exceeding 10%.

2. Strategic Updates and Business Highlights:

• Successful IPO of the senior housing business (Janus Living) raised $240 million, with Healthpeak retaining an 82% ownership stake.
• Acquired the Gateway campus in South San Francisco, signing 62,000 square feet in leases and letters of intent, with 113,000 square feet in active proposals.
• Joint venture with Blackstone on an outpatient portfolio raised $170 million, establishing a template for future transactions.
• Continued strong performance in outpatient medical, with positive cash re-leasing spreads of 5.4% and average annual escalators of 3%.
• Life science segment showed increased total occupancy and a robust leasing pipeline, with positive trends in M&A and capital raising in the biotech sector.

3. Forward Guidance and Outlook:

• Increased 2026 earnings guidance to a range of $1.71 to $1.75 per share.
• Expect IPO proceeds to be neutral to earnings in 2026 and accretive in 2027.
• Anticipate capturing an additional $0.04 per share in earnings as cash from the IPO is deployed into acquisitions.
• Projected lab occupancy to increase by at least 100 basis points by year-end 2026.

4. Bad News, Challenges, or Points of Concern:

• Incremental public company costs and temporary earnings drag from cash on the balance sheet post-IPO.
• Anticipated increase in interest expenses by $20 million and G&A costs by $5 million in 2026.
• Some concerns about the overall market for life science properties, with competitors facing challenges and potential downward pressure on rents.
• Noted that Q1 is typically a slower leasing quarter, which may impact short-term performance metrics.

5. Notable Q&A Insights:

• Management highlighted the strong demand in San Francisco, contrasting it with the broader market challenges faced by peers.
• The Gateway acquisition is performing better than initial underwriting expectations, with positive leasing activity.
• There is a cautious approach to future life science investments, emphasizing disciplined capital allocation.
• The team expressed confidence in achieving net absorption in both outpatient and life science segments, despite known tenant move-outs.
• Management reiterated that the focus remains on total occupancy and cash re-leasing spreads, rather than just face rents, to drive earnings growth.